Low detection limit spectrophotometry

An efficient, more sensitive and accurate spectrophotometric process is possible and can be used to obtain qualitative or quantitative results for analytes at limiting concentrations lower than usual. Transmission measurements (incident light power, P₀, or transmitted, P) are performed with a fluorescence spectrometer. One cell only is used to measure standards or unknown solutions, placed between the standard holder cuvette and the emission monochromator of the instrument. The source of the radiant power (P₀) is not the xenon lamp but the fluorescence or scattered radiation from the holder cuvette filled with an appropriate solution. The analyte concentration is found from a calibration graph, based upon Beer’s law or the approximate formula P₀−P=2.303P₀εbc, which is valid for dilute solutions. Determination of iron in a reference material, using 1,10-phenanthroline as the chromogenic reagent, was chosen as an example to demonstrate the suitability of the proposed method and clarify several important statistical questions. Also discussed is why and to what extent molecular fluorescence methods are more sensitive than molecular absorption methods.     

Preparations and spectroscopic studies of organotin complexes of diclofenac

The reactions of the potent and widely used anti-inflammatory drug diclofenac, HL, with diorganotin(IV) oxides were studied. The dimeric tetraorganodistannoxane complexes [Me(2)LSnOSnLMe(2)](2), [Bu(2)LSnOSnLBu(2)](2), [Ph(2)LSnOSnLPh(2)](2) and the dibutyltin complex [Bu(2)SnL(2)], have been prepared and structurally characterized in the solid state by means of vibrational and 119Sn M?ssbauer spectroscopy. Determination of lattice dynamics by temperature-dependent 119Sn M?ssbauer spectroscopy. From the variable-temperature M?ssbauer effect, the Debye temperature was determined. The complexes have been characterized in solution by NMR (1H and 13C) spectroscopy. Vibrational, M?ssbauer, and NMR data are discussed in terms of the proposed structures.     

Preparation,spectral and structural characterization of (2-benzoylpyridine N(4)-methyl-N(4)-phenylthiosemicarbazonato) chloropalladium(II)

The synthesis, as well as spectral and structural characterization, of (2-benzoylpyridine-N(4)-methyl-N(4)-phenylthiosemicarbazonato)chloropalladium(II), [Pd(Bz4MePh)Cl], is described. The unit cell contains two crystallographically independent molecules [Pd(1)(Bz4MePh)Cl], (1), and [Pd(2)(Bz4MePh)Cl], (2), stabilized by intra- and intermolecular hydrogen bonding. The distance between the Pd(1) and Pd(2) centres is 3.5038(11) Å. The spectroscopic techniques used in this study are the following: u.v.-visible, i.r. and ¹H n.m.r. The protonation constants, determined spectrophotometrically, of the uncoordinated HBz4MePh are pK_a1 = 10.82 ± 0.03 and pK_a2 = 4.09 ± 0.02.     

Synthesis and spectroscopic studies of iron (III) complex with a quinolone family member (pipemidic acid)

The interaction of iron (III) with pipemidic acid, Hpipem, afforded the complex [Fe (pipem) (HO)₂ (H₂O)]₂. The new complex has been characterised by elemental analyses, infra-red, EPR and XPS spectroscopies. The monoanion, pipem, exhibits O, O ligation through the carbonyl and carboxylato oxygen atoms. Six coordinate dimer distorted octahedral configuration has been proposed for [Fe (pipem) (HO)₂ (H₂O)]₂.     

Organotin mefenamic complexes—preparations,spectroscopic studies and crystal structure of a triphenyltin ester of mefenamic acid: novel anti‐tuberculosis agents

The triphenyltin adduct of mefenamic acid, [SnPh₃L] ( 1 ), the monophenyltin complex [PhSnOL] _n ( 2 ), and the dibutyltin complex [SnBu₂L₂] (3), where HL is 2‐[bis(2,3‐dimethylphenyl)amino]benzoic acid (mefenamic acid), have been prepared and structurally characterized by means of vibrational, ¹H and ¹³C NMR spectroscopies. The crystal structure of 1 has been determined by X‐ray crystallography. X‐ray analysis revealed a pseudo‐pentacoordinated structure containing Ph₃Sn coordinated to the carboxylato group. The structural distortion is a displacement from the tetrahedron toward the trigonal bipyramid. Significant C? H–π interactions and intramolecular hydrogen bonds stabilize the structure 1. The polar imino hydrogen atom participates in intramolecular hydrogen bonds. Complex 1 is self‐assembled via C? H–π and stacking interactions. Vibrational and NMR data are discussed in terms of the crystal structure and the proposed structures for 1–3. Compounds 1 and 3 were tested for antimycobacterial activity against Mycobacterium tuberculosis H37Rv. Copyright © 2002 John Wiley & Sons, Ltd.     

Crystallographic report: Diphenylbis(Hpiroxicam)tin(IV), [Ph2Sn(Hpir)2]

The crystal structure of complex [Ph₂Sn(Hpir)₂ ·CH₃CN] shows for the first time chelation to a metal atom of piroxicam through the keto‐enolate oxygen atoms. Copyright © 2004 John Wiley & Sons, Ltd.     

Synthesis and spectroscopic study of copper(II) and manganese(II) complexes with pipemidic acid

The interaction of copper(II) and manganese(II) with pipemidic acid, Hpipem, afforded the complexes [Cu(pipem)(2)(H(2)O)] x 2H(2)O, 1 and [Mn(pipem)(2)(H(2)O)], 2. The new complexes have been characterised by elemental analyses, infrared, UV-vis and X-band EPR spectroscopy in the temperature range from 4 to 300 K. The monoanion, pipem, exhibits O,O ligation through the carbonyl and carboxylato oxygen atoms. Five coordinate square-pyramid configuration has been proposed for 1 and 2, and the fifth apical position is occupied by a coordinated water molecule.     

Synthesis,characterization, crystal structures, in vitro and in vivo antitumor activity of palladium(II) and zinc(II) complexes with 2-formyl and 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone

The present paper includes synthesis and spectral characterization of the novel prepared palladium(II) and zinc(II) complexes with 2-formyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone, HFo4Npypipe, 1 and the 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone, HAc4Npypipe, 2. The Pd(II) complexes [PdCl(Fo4Npypipe)], 3, [PdCl(Ac4Npypipe)], 4 and the Zn(II) complexes [ZnCl₂(Fo4Npypipe)], 5 and [ZnCl₂(Ac4Npypipe)], 6 have been characterized by elemental analyses and spectroscopic studies. The crystal structure of the complexes [PdCl(Fo4Npippy)], 3 and [PdCl(Ac4Npippy)], 4, have been solved by single-crystal X-ray diffraction. The electronic, IR, UV/Vis, and NMR spectroscopic data of the complexes are reported. The results of the cytotoxic activity of 1–6 have been evaluated in vitro against the cells of three human cancer cell lines: MCF-7, T24, A-549 and a mouse L-929 (a fibroblast-like cell line cloned from strain L). For selected compounds 2 and 6 the acute toxicity and antitumor activity were evaluated on leukemia P388-bearing mice. The Zn(II) compounds 5 and 6 are considered as agents with potential antitumor activity, and can therefore be candidates for further stages of screening in vitro and/or in vivo.     

Condensation Reaction of Dimethyltin(IV) Oxide with 2‐(2,3‐Dichloroanilino)benzoic Acid Synthesis and Study of a Novel Dimeric Tetraorganodistannoxane

The novel symmetric dimeric tetraorganodistannoxane [(Me₂Sn)₄(DCPA)₂)O₂(OH)₂] ( 2 ) and [(Me₂Sn)₄(DCPA)₂)O₂(OC₂H₅)₂] ( 3 ) where HDCPA is 2‐(2,3‐dichloroanilino)benzoic acid ( 1 ) have been prepared. The crystal structure of 3 has been determined by X‐ray crystallography. Three distannoxane rings are present to the centrosymmetric dimeric tetraorganodistannoxane by virtue of μ₃‐oxo form the central R₄Sn₂O₂ core with a planar Sn₂O₂ ring, resulting in a ladder type structural motif. Five‐coordinated tin atoms are present in the distannoxane dimer. The ligands act as monodentate agents, thus rendering the tin atom five‐coordinated. Significant π → π stacking interactions and intramolecular hydrogen bonds stabilize the structure 3 . The polar imino hydrogen atom participates in intramolecular hydrogen bonds. The formation of the dimeric distannoxanes 2 and 3 represent a ladder‐type carboxylates in which the insertion of a μ₂‐OH or a μ₂‐OC₂H₅ group occurs. This unusual result can be interpreted in terms of a competition between the strength different donors, in which the –OH or the –OC₂H₅ groups show higher donor capacity than the carboxylato group of DCPA.     

Fluorimetric determination of calcium in serum with calcein : Complexation of Calcein with Calcium and Alkali Metals

Calcium (0–50 μM) is determined by measuring the fluorescence of its calcein complexes in strongly alkaline solutions. The effects of alkali metal complexation are described, and the nature of the calcium complexes is investigated. The method is applied to serum.